+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Artificial Intelligence (AI) In Drug Discovery Global Market Report 2021: COVID-19 Growth and Change to 2030

  • ID: 5446053
  • Report
  • September 2021
  • Region: Global
  • 175 Pages
  • The Business Research Company

FEATURED COMPANIES

  • Atomwise Inc.
  • BIOAGE
  • Deep Genomics
  • Google
  • Microsoft
  • OWKIN Inc.
Artificial Intelligence (AI) In Drug Discovery Global Market Report 2021: COVID-19 Growth and Change to 2030 provides the strategists, marketers and senior management with the critical information they need to assess the global artificial intelligence (AI) in drug discovery market.







This report focuses on the artificial intelligence (AI) in drug discovery market which is experiencing strong growth. The report gives a guide to the artificial intelligence (AI) in drug discovery market which will be shaping and changing our lives over the next ten years and beyond, including the market's response to the challenge of the global pandemic.

Reasons to Purchase


  • Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis

Description:


Where is the largest and fastest growing market for artificial intelligence (AI) in drug discovery? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Artificial Intelligence (AI) In Drug Discovery market global report answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography. It places the market within the context of the wider artificial intelligence (AI) in drug discovery market, and compares it with other markets.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, the influence of the COVID-19 virus and forecasting its growth.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
  • The artificial intelligence (AI) in drug discovery market section of the report gives context. It compares the artificial intelligence (AI) in drug discovery market with other segments of the artificial intelligence (AI) in drug discovery market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, artificial intelligence (AI) in drug discovery indicators comparison.

Scope


Markets Covered:


  • By Technology: Deep Learning; Machine Learning
  • By Drug Type: Small Molecule; Large Molecules
  • By Therapeutic Type: Metabolic Disease; Cardiovascular Disease; Oncology; Neurodegenerative Diseases; Others
  • By End-Users: Pharmaceutical Companies; Biopharmaceutical Companies; Academic and Research Institutes; Others

Companies Mentioned:


IBM Corporation; Microsoft; Atomwise Inc.; Deep Genomics; Cloud Pharmaceuticals

Countries:


Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA

Regions:


Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time Series:


Five years historic and ten years forecast.

Data:


Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.

Data segmentations:


Country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing:


Data and analysis throughout the report is sourced using end notes.


This product will be delivered within 1-3 business days.
Frequently Asked Questions about the Global Artificial Intelligence (AI) in Drug Discovery Market

What is the estimated value of the Global Artificial Intelligence (AI) in Drug Discovery Market?

The Global Artificial Intelligence (AI) in Drug Discovery Market was estimated to be valued at $0.5 billion in 2021.

What is the growth rate of the Global Artificial Intelligence (AI) in Drug Discovery Market?

The growth rate of the Global Artificial Intelligence (AI) in Drug Discovery Market is 37.7%, with an estimated value of $1.7 billion by 2025.

What is the forecasted size of the Global Artificial Intelligence (AI) in Drug Discovery Market?

The Global Artificial Intelligence (AI) in Drug Discovery Market is estimated to be worth $1.7 billion by 2025.

Who are the key companies in the Global Artificial Intelligence (AI) in Drug Discovery Market?

Key companies in the Global Artificial Intelligence (AI) in Drug Discovery Market include IBM Corporation, Microsoft, Atomwise Inc., Deep Genomics, Cloud Pharmaceuticals, Insilico Medicine, Benevolent AI, Exscientia and BIOAGE.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Atomwise Inc.
  • BIOAGE
  • Deep Genomics
  • Google
  • Microsoft
  • OWKIN Inc.

1. Executive Summary2. Artificial Intelligence (AI) In Drug Discovery Market Characteristics3. Artificial Intelligence (AI) In Drug Discovery Market Trends and Strategies4. Impact Of COVID-19 On Artificial Intelligence (AI) In Drug Discovery
5. Artificial Intelligence (AI) In Drug Discovery Market Size and Growth
5.1. Global Artificial Intelligence (AI) In Drug Discovery Historic Market, 2015-2020, $ Billion
5.1.1. Drivers Of the Market
5.1.2. Restraints On the Market
5.2. Global Artificial Intelligence (AI) In Drug Discovery Forecast Market, 2020-2025F, 2030F, $ Billion
5.2.1. Drivers Of the Market
5.2.2. Restraints On the Market
6. Artificial Intelligence (AI) In Drug Discovery Market Segmentation
6.1. Global Artificial Intelligence (AI) In Drug Discovery Market, Segmentation by Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Deep Learning
  • Machine Learning
6.2. Global Artificial Intelligence (AI) In Drug Discovery Market, Segmentation by Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Small Molecule
  • Large Molecules
6.3. Global Artificial Intelligence (AI) In Drug Discovery Market, Segmentation by therapeutic Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Metabolic Disease
  • Cardiovascular Disease
  • Oncology
  • Neurodegenerative Diseases
  • Others
6.4. Global Artificial Intelligence (AI) In Drug Discovery Market, Segmentation by End-Users, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Pharmaceutical Companies
  • Biopharmaceutical Companies
  • Academic and Research Institutes
  • Others

7. Artificial Intelligence (AI) In Drug Discovery Market Regional and Country Analysis
7.1. Global Artificial Intelligence (AI) In Drug Discovery Market, Split by Region, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
7.2. Global Artificial Intelligence (AI) In Drug Discovery Market, Split by Country, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
8. Asia-Pacific Artificial Intelligence (AI) In Drug Discovery Market
8.1. Asia-Pacific Artificial Intelligence (AI) In Drug Discovery Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Artificial Intelligence (AI) In Drug Discovery Market, Segmentation by Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
8.3. Asia-Pacific Artificial Intelligence (AI) In Drug Discovery Market, Segmentation by Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
9. China Artificial Intelligence (AI) In Drug Discovery Market
9.1. China Artificial Intelligence (AI) In Drug Discovery Market Overview
9.2. China Artificial Intelligence (AI) In Drug Discovery Market, Segmentation by Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F,$ Billion
9.3. China Artificial Intelligence (AI) In Drug Discovery Market, Segmentation by Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F,$ Billion
10. India Artificial Intelligence (AI) In Drug Discovery Market
10.1. India Artificial Intelligence (AI) In Drug Discovery Market, Segmentation by Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
10.2. India Artificial Intelligence (AI) In Drug Discovery Market, Segmentation by Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
11. Japan Artificial Intelligence (AI) In Drug Discovery Market
11.1. Japan Artificial Intelligence (AI) In Drug Discovery Market, Segmentation by Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
11.2. Japan Artificial Intelligence (AI) In Drug Discovery Market, Segmentation by Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
12. Australia Artificial Intelligence (AI) In Drug Discovery Market
12.1. Australia Artificial Intelligence (AI) In Drug Discovery Market, Segmentation by Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
12.2. Australia Artificial Intelligence (AI) In Drug Discovery Market, Segmentation by Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
13. Indonesia Artificial Intelligence (AI) In Drug Discovery Market
13.1. Indonesia Artificial Intelligence (AI) In Drug Discovery Market, Segmentation by Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
13.2. Indonesia Artificial Intelligence (AI) In Drug Discovery Market, Segmentation by Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
14. South Korea Artificial Intelligence (AI) In Drug Discovery Market
14.1. South Korea Artificial Intelligence (AI) In Drug Discovery Market, Segmentation by Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
14.2. South Korea Artificial Intelligence (AI) In Drug Discovery Market, Segmentation by Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
15. Western Europe Artificial Intelligence (AI) In Drug Discovery Market
15.1. Western Europe Artificial Intelligence (AI) In Drug Discovery Market Overview
15.2. Western Europe Artificial Intelligence (AI) In Drug Discovery Market, Segmentation by Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
15.3. Western Europe Artificial Intelligence (AI) In Drug Discovery Market, Segmentation by Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
16. UK Artificial Intelligence (AI) In Drug Discovery Market
16.1. UK Artificial Intelligence (AI) In Drug Discovery Market, Segmentation by Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
16.2. UK Artificial Intelligence (AI) In Drug Discovery Market, Segmentation by Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
17. Germany Artificial Intelligence (AI) In Drug Discovery Market
17.1. Germany Artificial Intelligence (AI) In Drug Discovery Market, Segmentation by Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
17.2. Germany Artificial Intelligence (AI) In Drug Discovery Market, Segmentation by Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
18. France Artificial Intelligence (AI) In Drug Discovery Market
18.4. France Artificial Intelligence (AI) In Drug Discovery Market, Segmentation by Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
18.5. France Artificial Intelligence (AI) In Drug Discovery Market, Segmentation by Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
19. Eastern Europe Artificial Intelligence (AI) In Drug Discovery Market
19.1. Eastern Europe Artificial Intelligence (AI) In Drug Discovery Market Overview
19.2. Eastern Europe Artificial Intelligence (AI) In Drug Discovery Market, Segmentation by Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
19.3. Eastern Europe Artificial Intelligence (AI) In Drug Discovery Market, Segmentation by Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
20. Russia Artificial Intelligence (AI) In Drug Discovery Market
20.1. Russia Artificial Intelligence (AI) In Drug Discovery Market, Segmentation by Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
20.2. Russia Artificial Intelligence (AI) In Drug Discovery Market, Segmentation by Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
21. North America Artificial Intelligence (AI) In Drug Discovery Market
21.1. North America Artificial Intelligence (AI) In Drug Discovery Market Overview
21.2. North America Artificial Intelligence (AI) In Drug Discovery Market, Segmentation by Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
21.3. North America Artificial Intelligence (AI) In Drug Discovery Market, Segmentation by Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
22. USA Artificial Intelligence (AI) In Drug Discovery Market
22.1. USA Artificial Intelligence (AI) In Drug Discovery Market Overview
22.2. USA Artificial Intelligence (AI) In Drug Discovery Market, Segmentation by Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
22.3. USA Artificial Intelligence (AI) In Drug Discovery Market, Segmentation by Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
23. South America Artificial Intelligence (AI) In Drug Discovery Market
23.1. South America Artificial Intelligence (AI) In Drug Discovery Market Overview
23.2. South America Artificial Intelligence (AI) In Drug Discovery Market, Segmentation by Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
23.3. South America Artificial Intelligence (AI) In Drug Discovery Market, Segmentation by Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
24. Brazil Artificial Intelligence (AI) In Drug Discovery Market
24.1. Brazil Artificial Intelligence (AI) In Drug Discovery Market, Segmentation by Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
24.2. Brazil Artificial Intelligence (AI) In Drug Discovery Market, Segmentation by Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
25. Middle East Artificial Intelligence (AI) In Drug Discovery Market
25.1. Middle East Artificial Intelligence (AI) In Drug Discovery Market Overview
25.2. Middle East Artificial Intelligence (AI) In Drug Discovery Market, Segmentation by Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
25.3. Middle East Artificial Intelligence (AI) In Drug Discovery Market, Segmentation by Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
26. Africa Artificial Intelligence (AI) In Drug Discovery Market
26.1. Africa Artificial Intelligence (AI) In Drug Discovery Market Overview
26.2. Africa Artificial Intelligence (AI) In Drug Discovery Market, Segmentation by Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
26.3. Africa Artificial Intelligence (AI) In Drug Discovery Market, Segmentation by Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
27. Artificial Intelligence (AI) In Drug Discovery Market Competitive Landscape and Company Profiles
27.1. Artificial Intelligence (AI) In Drug Discovery Market Competitive Landscape
27.2. Artificial Intelligence (AI) In Drug Discovery Market Company Profiles
27.2.1. IBM Corporation
27.2.1.1. Overview
27.2.1.2. Products and Services
27.2.1.3. Strategy
27.2.1.4. Financial Performance
27.2.2. Microsoft
27.2.2.1. Overview
27.2.2.2. Products and Services
27.2.2.3. Strategy
27.2.2.4. Financial Performance
27.2.3. Atomwise Inc.
27.2.3.1. Overview
27.2.3.2. Products and Services
27.2.3.3. Strategy
27.2.3.4. Financial Performance
27.2.4. Deep Genomics
27.2.4.1. Overview
27.2.4.2. Products and Services
27.2.4.3. Strategy
27.2.4.4. Financial Performance
27.2.5. Cloud Pharmaceuticals
27.2.5.1. Overview
27.2.5.2. Products and Services
27.2.5.3. Strategy
27.2.5.4. Financial Performance
28. Key Mergers and Acquisitions in the Artificial Intelligence (AI) In Drug Discovery Market29. Artificial Intelligence (AI) In Drug Discovery Market Future Outlook and Potential Analysis
30. Appendix
30.1. Abbreviations
30.2. Currencies
30.3. Research Inquiries
30.4. About the Publisher
30.5. Copyright and Disclaimer
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Atomwise Inc.
  • BIOAGE
  • Deep Genomics
  • Google
  • Microsoft
  • OWKIN Inc.
Major players in the artificial intelligence (AI) in drug discovery market are IBM Corporation, Microsoft, Atomwise Inc., Deep Genomics, Cloud Pharmaceuticals, Insilico Medicine, Benevolent AI, Exscientia, Cyclica, and BIOAGE.

The global artificial intelligence (AI) in drug discovery market is expected to grow from $0.36 billion in 2020 to $0.47 billion in 2021 at a compound annual growth rate (CAGR) of 30.6%. The growth is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The market is expected to reach $1.69 billion in 2025 at a CAGR of 38%.

The artificial intelligence (AI) in drug discovery market consists of sales of AI for drug discovery and related services. Artificial Intelligence (AI) for drug discovery is a technology that uses a simulation of human intelligence process by machines to tackle complex problems in the drug discovery process. It helps to find new molecules to identify drug targets and develop personalized medicines in the pharmaceutical industry.

The artificial intelligence (AI) in drug discovery market covered in this report is segmented by technology into deep learning, machine learning. It is also segmented by drug type into small molecule, large molecules; by therapeutic type into metabolic disease, cardiovascular disease, oncology, neurodegenerative diseases, others and by end-users into pharmaceutical companies, biopharmaceutical companies, academic and research institutes, others.

The regions covered in this report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The shortage of skilled professionals is expected to hamper the AI in drug discovery market. The employees have to re-train or learn new skill sets to work efficiently on the complex AI machines to get the desired results for the drug. The shortage of skills acts as a major hindrance to drug discovery through AI, discouraging companies to adopt AI-based machines for drug discovery. According to The Pistoia Alliance, a global non-profit organization that works to encourage innovation in life sciences R&D cited that 44% of respondents agree that lack of skills was the biggest barrier to the adoption of AI and machine learning (ML) in 2019.

In July 2020, Curi Bio, a leading developer of human iPSC-based platforms for drug discovery, acquired Dana Solutions for an undisclosed amount. This acquisition will give Curi Bio access to Dana's AI/ML platforms for modelling cell and tissue phenotype, automated platform for contractility analysis of beating cardiomyocyte and platform for predictive safety pharmacology. Dana Solutions is a leading AI solutions provider for the life sciences industry.

The rise in demand for a reduction in the overall time taken for the drug discovery process is a key driver propelling the growth of the artificial intelligence (AI) in drug discovery market. Traditionally, it takes three to five years for animal models to identify and optimize molecules before they are evaluated in humans whereas start-ups based on AI have been identifying and designing new drugs in a matter of few days or months. For instance, in 2020, the British start-up Exscientia and Japan's Sumitomo Dainippon Pharma have used artificial intelligence to produce an obsessive-compulsive disorder (OCD) medication, decreasing the development time from four years to less than one year. The reduction in overall time taken for the drug discovery process drives the artificial intelligence (AI) in drug discovery market’s growth.

Major companies operating in the AI drug delivery market are adopting strategic collaborations to research and discover drugs using AI and are gaining significant popularity in the artificial intelligence in drug discovery market. For instance, in September 2019, Atomwise Inc. and Jiangsu Hansoh Pharmaceutical Group Co. Ltd announced the collaboration of $1.5 billion to design and discover the potential drug candidates for up to 11 undisclosed target proteins in cancer and other therapeutic areas. The collaboration is expected to combine Atomwise Inc’s AI technology, protein structure expertise, and medicinal chemistry with Jiangsu Hansoh Pharmaceutical Group Co. Ltd’s manufacturing, research & development, and commercial capabilities in order to improve and accelerate clinical development and drug discovery process.

The countries covered in the market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.
Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • IBM Corporation
  • Microsoft
  • Atomwise Inc.
  • Deep Genomics
  • Cloud Pharmaceuticals
  • Insilico Medicine
  • Benevolent AI
  • Exscientia
  • Cyclica
  • BIOAGE
  • Numerate
  • Numedii
  • Envisagenics
  • twoXAR
  • OWKIN Inc.
  • XtalPi
  • Berg LLC
  • Google
  • Verge Genomics
Note: Product cover images may vary from those shown

Loading
LOADING...